DNA Next Generation Sequencing Market Overview and Growth by 2025

Historic Data: 2015-2016   |   Base Year: 2017   |   Forecast Period: 2018-2025

DNA Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts By Product (Platforms, Services and Consumables); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users) and Geography

  • Report Date : Jan 2019
  • Report Code : TIPRE00002934
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 246

[Research Report] The DNA next generation sequencing market size is estimated to reach US$ 22,716.9 million by 2025 from US$ 4,898.5 million in 2017; it is expected to grow at a CAGR of 21.7% during 2018-2025.

Next generation sequencing is also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA samples. NGS is driving the drug discovery application and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. Moreover, next-generation sequencing (NGS) is a massively parallel sequencing technology that can establish the order of nucleotides in a whole genome with scalability, ultra-high throughput, and fast speed. Since it includes preparing the sample for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important processes in the total sequencing protocol. In the global healthcare sector, NGS is steadily being integrated into clinical laboratory analysis, testing, and disease diagnoses. In pharmacogenomics, NGS has been widely employed to speed up the drug discovery process.

The DNA next generation sequencing market growth is attributed owing to increasing number of cancer cases across the globe, rising research studies, increasing collaborations between research institutes and market players along with rising applications of DNA next generation sequencing and technological advancements in sequencing technologies. However, the dearth of skilled professionals is expected to critically impact the overall DNA next generation sequencing market growth.

 

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

DNA Next Generation Sequencing Market: Strategic Insights

dna-next-generation-sequencing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Declining Price of Sequencing and Technological Advancements in Sequencing Methods Drives DNA Next Generation Sequencing Market

In the recent years, next generation sequencing prices have declined substantially. In 2000, the cost for sequencing human genome was US$ 3.7 billion and took 13 years for completion. However, the costs for the same in recent years reduced to US$ 10 million in 2006 and further declined in 2012, and the process requires fewer days. Major DNA next generation sequencing market players such as Illumina and Roche have introduced breakthrough technologies that are cost-efficient and require less time in sequencing processes.

Moreover, advancement in the field of molecular biology has equally enhanced sequencing procedures. Many industry players have come up with innovative NGS technology in the last few years. For instance, Pacific Biosciences with Sequel and Oxford Nanopore with PromethION. Additionally, three advanced NSG systems that dominate the market include Roche GS FLX (454), Illumina HiSeq 2000 (Solexa), and AB SOLiD (Agencourt).

Further modification and automation of this process continued to increase sequencing data and also resulted in managing time more efficiently, thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence-based gene expression analysis a “digital” alternative to analog techniques. Advancement in genome sequencing has made sequencing easy and accurate. These technological advancements are likely to boost the DNA next generation sequencing market size in the near future.

Product-Based Insights

The global DNA next generation sequencing market, based on product, is segmented into platforms, services, and consumables. The platform segment is further sub-segmented into HiSeq Series, MiSeq Series, SOLiD, Ion Torrent, Pacbio Rs II and Sequel Systems, and others. Further, the services segment is sub-segmented into sequencing services and data management and analysis services. Moreover, the consumables segment is sub-segmented into sample consumable preparation and other NGS consumables. The consumables segment held a larger share among the product subsegments in the DNA next generation sequencing market in 2017 and is also anticipated to follow a similar trend over the forecast period. More recent NGS platforms have adopted a new sequencing method, called single-molecule sequencing (SMS), which does not require prior amplification of DNA, thus avoiding the PCR-related error reads or amplification bias toward repeat regions. During the past five years, next-generation sequencing (NGS) has transitioned from research to clinical use. At least 14 countries have created initiatives to sequence large populations, and it is projected that more than 60 million people worldwide will have their genome sequenced by 2025.

Application-Based Insights

The global DNA next generation sequencing market, based on application, is segmented into diagnostics, drug discovery, precision medicine, and other applications. The diagnostics segment held the largest share in 2017 and is expected to witness significant growth over the next five to six years. The use of next-generation sequencing (NGS) technology in diagnostic genome care needs precision and accuracy. The NGS technologies use cost-efficient sequencing to gain genomic information about the patients from the whole-genome sequencing to perform clinical actions. Next-generation sequencing is eventually substituting conventional technologies to diagnose various genetic disorders. Large sets of genes can now be addressed in a single test instead of a gene-by-gene approach.

End User-Based Insights

The global market, based on end user, is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and other end users. The academic and research institutes segment is expected to witness the highest growth over the forecast period. The sequence helps scientists in finding the kind of genetic information that is carried in a particular DNA segment. For example, scientists can use sequence information to determine which stretches of DNA contain genes and which stretches carry regulatory instructions, turning genes on or off. The automated-industrialized approach based on random or shotgun sequencing was introduced by The Institute for Genomic Research (TIGR) in Rockville, Maryland, and resulted in the publication of 337 new human genes and 48 homologous genes from other organisms 

 

DNA Next Generation Sequencing Market Regional Insights

The regional trends and factors influencing the DNA Next Generation Sequencing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses DNA Next Generation Sequencing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

dna-next-generation-sequencing-market-global-geography
  • Get the Regional Specific Data for DNA Next Generation Sequencing Market

DNA Next Generation Sequencing Market Report Scope

Report Attribute Details
Market size in 2017 US$ 4.9 Billion
Market Size by 2025 US$ 22.72 Billion
Global CAGR (2017 - 2025) 21.7%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By Product
  • Platforms
  • Services and Consumables
By Application
  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • & Other Applications
By End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals Clinics
  • & Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.

  • DNA Next Generation Sequencing Market Players Density: Understanding Its Impact on Business Dynamics

    The DNA Next Generation Sequencing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the DNA Next Generation Sequencing Market are:

    1. Illumina, Inc.
    2. Thermo Fisher
    3. Qiagen N.V.
    4. Beijing Genomics Institute
    5. PerkinElmer, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    dna-next-generation-sequencing-market-cagr

    • Get the DNA Next Generation Sequencing Market top key players overview

    Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The market share is anticipated to flourish with the development of new innovative products by market players. Some of the market participants present in the concerned market are THERMO FISHER SCIENTIFIC INC.; Illumina, Inc; Qiagen N.V.; Beijing Genomics Institute; PerkinElmer, Inc.; F.Hoffman-La Roche Ltd.; Agilent Technologies; Eurofins Scientific; Oxford Nanopore Technologies Ltd; and Macrogen Inc.


    Frequently Asked Questions

    What is the market CAGR value of DNA next generation sequencing market during forecast period?

    The DNA next generation sequencing market is growing at CAGR of 21.7% from 2018-2025.

    Who are the key players in the DNA next generation sequencing market?

    Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

    What would be the market value of DNA next generation sequencing market in 2025?

    As per forecast report, the market value of DNA next generation sequencing market in 2025 will be US$ 22,716.9 Million.

    What are the key growth drivers for the DNA next generation sequencing market?

    The growth of the global DNA next generation sequencing market is attributed to the increases in cancer prevalence, technological development and decreasing price of sequencing. Owing to factors like advances within the field of genetic science, development in several ways and methods for sequencing, there's a notable decline within the price of sequencing.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies

    1. Illumina, Inc.
    2. Thermo Fisher
    3. Qiagen N.V.
    4. Beijing Genomics Institute
    5. PerkinElmer, Inc.
    6. Hoffman-La Roche Ltd.
    7. Agilent Technologies
    8. Eurofins Scientific
    9. Oxford Nanopore Technologies Ltd.
    10. Macrogen Inc.

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo